<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0200269.ref041">
 <label>41</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Fierer</surname>
   <given-names>DS</given-names>
  </name>, 
  <name>
   <surname>Dieterich</surname>
   <given-names>DT</given-names>
  </name>, 
  <name>
   <surname>Mullen</surname>
   <given-names>MP</given-names>
  </name>, 
  <name>
   <surname>Branch</surname>
   <given-names>AD</given-names>
  </name>, 
  <name>
   <surname>Uriel</surname>
   <given-names>AJ</given-names>
  </name>, 
  <name>
   <surname>Carriero</surname>
   <given-names>DC</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men</article-title>. 
  <source>Clin Infect Dis</source>. 
  <year>2014</year>;
  <volume>58</volume>(
  <issue>6</issue>):
  <fpage>873</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.1093/cid/cit799</pub-id> ; PubMed Central PMCID: PMC3935497.
  <?supplied-pmid 24336914?>
  <pub-id pub-id-type="pmid">24336914</pub-id>
 </mixed-citation>
</ref>
